Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Journal of Clinical Outcomes Management : JCOM|May 10, 2016
Cardiorenal Syndrome Type 1: Renal Dysfunction in Acute Decompensated Heart FailureKurt W Prins, Thenappan Thenappan, Jeremy S Markowitz, et al.
BMJ (Clinical Research Ed.)|March 16, 2018
Pulmonary arterial hypertension: pathogenesis and clinical managementThenappan Thenappan, Mark L Ormiston, John J Ryan, et al.
The American Journal of Medicine|October 25, 2011
Cardiac amyloidosis: a practical approach to diagnosis and managementPrashant Kapoor, Thenappan Thenappan, Ekta Singh, et al.
Chest|May 22, 2021
A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic ShuntJasmine H Tatah, E Kenneth Weir, Kurt W Prins, et al.
Pulmonary Circulation|July 7, 2017
Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysisKurt W Prins, Sue Duval, Jeremy Markowitz, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 29, 2010
Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertensionDalia Urboniene, Idith Haber, Yong-Hu Fang, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 14, 2018
Prevalence of Myocardial Fibrosis by Left Ventricular Assist Device Apical Core Biopsy and Correlation with Other Markers of Myocardial RecoveryJessica Schultz, Ranjit John, Cindy Martin, et al.
JACC. Basic to Translational Science|December 6, 2021
With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial HypertensionSasha Z Prisco, Megan Eklund, Rashmi Raveendran, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Ketone Bodies in Right Ventricular Failure: A Unique Therapeutic OpportunityMadelyn Blake, Patrycja Puchalska, Felipe Kazmirczak, et al.
Circulation. Heart Failure|October 4, 2014
β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysisThenappan Thenappan, Samit S Roy, Sue Duval, et al.
Pageof 11